$NASDAQ:RARE

Ultragenyx Pharmaceutical Intrinsic Value – Assenagon Asset Management S.A. Sells Shares of Ultragenyx Pharmaceutical in 2023.

Trending News ☀️ In 2023, Assenagon Asset Management S.A. sold shares of Ultragenyx Pharmaceutical ($NASDAQ:RARE) Inc. Ultragenyx is a biopharmaceutical [...]

By |March 29, 2023|Categories: Biotechnology, Intrinsic Value|Tags: , , |0 Comments

ULTRAGENYX PHARMACEUTICAL Reports Q4 FY2022 Earnings with 24.0% Revenue Decrease and 23.9% Net Income Increase.

Earnings report ULTRAGENYX PHARMACEUTICAL ($NASDAQ:RARE) reported their fourth quarter of FY2022 earnings results on February 16 2023. For the end [...]

By |March 7, 2023|Categories: Biotechnology, Earnings Report|Tags: , , |0 Comments

Ultragenyx Pharmaceutical Intrinsic Value Calculation – Jump Financial LLC Increases Investment in Ultragenyx Pharmaceutical

Trending News 🌥️ Ultragenyx Pharmaceutical Intrinsic Value Calculation - Ultragenyx Pharmaceutical ($NASDAQ:RARE) Inc. is a biopharmaceutical company that is focused [...]

By |February 10, 2023|Categories: Biotechnology, Intrinsic Value|Tags: , , |0 Comments

ULTRAGENYX PHARMACEUTICAL Jumps 4.63% in a Week, leaving Investors Wondering where it will go Next

Trending News 🌥️ Ultragenyx Pharmaceutical Intrinsic Value – ULTRAGENYX ($NASDAQ:RARE): Ultagenyx Pharmaceutical Inc. is a clinical-stage biopharmaceutical company committed to [...]

By |November 21, 2022|Categories: Intrinsic Value|Tags: , , |0 Comments
Go to Top